Thomaso Crawford News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial

Topline data from Phase 3 trial expected in Q4 2024 Company to present encore 36-month efficacy, safety, and patient-reported outcomes data from the Phase 2 TOPAZ trial extension at the 2023.

North charlestonSouth carolinaUnited statesJay backstromThomaso crawfordJohns hopkins universityWorld muscle societyCharleston area convention centerScholar rock incDrug administrationEuropean medicines agencyExchange commissionScholar rockAnnual congressChief executive officerRevised hammersmith scale

New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy

New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesRushmie nofsingerTeagan whiteDisney swanThomas crawfordJay backstromThomaso crawfordResearch clinical care meetingDolphin hotelsResearch clinical care meeting in orlandoDrug administrationScholar rock incExchange commissionEuropean medicines agencyJohns hopkins university